BioSpace News Archive

The U.S. Food and Drug Administration (FDA) has granted QT Imaging, Inc. 510(K) clearance to calculate the fibroglandular volume (FGV) of the breast and the ratio of FGV to total breast volume (TGV).

BioSig Technologies, Inc. today announced the release of PURE EP™ Software Version 6 with ACCUVIZ™ Module.

Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global leader in photonics-based health monitoring and communications solutions, today announced that it has developed what it believes to be the world’s first micro-transfer-printed (mTP) silicon-photonics-based laser for commercial applications.

Medical device and technology company Lazurite™ Holdings LLC announced today that it is working with LG Electronics USA as a reseller of LG’s high-performance surgical display monitors.

The American Diabetes Association® announced a new initiative designed to address the urgent public health challenge of preventable amputation called the Amputation Prevention Alliance.

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, awarded $525,000 in grants to eight federally qualified health centers focused on improving colorectal cancer screening rates in vulnerable populations.

The Alzheimer’s Drug Discovery Foundation has named Miranda E. Orr, PhD, Assistant Professor of Gerontology and Geriatric Medicine at the Wake Forest University School of Medicine, as the recipient of the 2022 Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Development.

The latest market analysis report published by Reports and Data, titled ‘Global Optic Nerve Diseases Treatment Market – Forecast to 2030,’ thoroughly examines the Optic Nerve Diseases Treatment industry to provide essential data & information for the targeted readers.

Henry Ford Health, and GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced Henry Ford Health as the first healthcare provider in Michigan to offer Galleri®, GRAIL’s Multi-Cancer Early Detection (MCED) blood test.

The global Adipose-derived Stem Cell Market size is expected to reach USD 2.34 billion by 2025, according to a new report by Emergen Research, growing at a CAGR of 18.3% over the forecast period.